Artificial Vital Organs and Medical Bionics Market Outlook, Major Players, Industry Analysis and Forecasts to 2027
IMARC Group has recently released a new research study “Artificial Vital Organs and Medical Bionics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of artificial vital organs and medical bionics market ?
The global artificial vital organs and medical bionics market size reached US$ 41.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 60.67 Billion on by 2027, exhibiting a growth rate (CAGR) of 6.50% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What is a the artificial vital organs and medical bionics Market ?
Artificial vital organs and medical bionics represent specifically engineered devices that can be implanted into the human body to replace affected natural organs. They can be categorized into artificial liver, artificial heart, artificial pancreas, bionic limbs, vision and ear bionics, exoskeletons, heart valves, etc.
These artificial vital organs and medical bionics are designed to provide long-term safety and instill effective motor or sensory-motor function to nerve or muscle tissues. They are even used to develop cloned liver cells that aid in filtering toxins from the plasma and secreting albumin proteins and clotting factors as in the normal liver.
Request For Sample Report: https://www.imarcgroup.com/artificial-vital-organs-medical-bionics-market/requestsample
Artificial vital organs and medical bionics help to design an intravenous membrane oxygenator (IMO) that is integrated directly into the vena cava system to oxygenate blood as it circulates back to the heart before reaching the natural lungs. Consequently, they find extensive utilization in hospitals, clinics, and other healthcare establishments across the globe.
What are the major market drivers in a artificial vital organs and medical bionics market ?
The rising prevalence of several diseases, such as respiratory ailments, cirrhosis, cardiovascular disorders, and kidney and liver failures, is among the key factors driving the artificial vital organs and medical bionics market.
In addition to this, the growing geriatric population, which is highly prone to various organ disorders, is acting as another significant growth-inducing factor.
Furthermore, the development of numerous novel products, including full-functioning artificial lungs, hearts, livers, urethras, windpipes, livers, etc., is also positively influencing the market growth.
Besides this, the inflating investments in research and development (R&D) activities to innovate new techniques of organ regeneration through engineered tissues are further catalyzing the global market.
Moreover, the launch of bioartificial organs with enhanced survival rates and faster recuperation of patients is expected to propel the artificial vital organs and medical bionics market over the forecasted period.
Click here to view detailed information with table of content: https://www.imarcgroup.com/artificial-vital-organs-medical-bionics-market
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Product Type:
Artificial Vital OrgansArtificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Oxygenators
Medical BionicsBionic Limbs
Vision Bionics
Ear Bionics
Exoskeletons
Brain Bionics
Heart Valves
Cardiac Bionics
Breakup by Application:
Hospitals
Clinics
Others
By Geography:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are
Abiomed, BiVACOR Inc
CARMAT
Cirtec Medical
Edwards Lifesciences
Ekso Bionics Holdings Inc.
Nikkiso Co. Ltd.
Second Sight Medical Products Inc
and SynCardia Systems LLC (Picard Medical Inc.).
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Leave a Comment:
To notify a previous commenter, mention their user name: @peter or @peter-smith if there are spaces.
